We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current XBIT market cap is 114.14M. The company's latest EPS is USD -1.0809 and P/E is -3.47.
| Quarter End | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.59M | -7.51M | -4.15M | -5.62M | -5.12M |
| Net Income | -6.21M | -7.25M | -4.07M | -5.91M | -5.05M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.43M | 0 | 44M | 18.39M | 4.01M |
| Operating Income | -20.22M | -29.53M | -15.6M | -23.61M | -33.46M |
| Net Income | -21.14M | 668.63M | -11.22M | -17.41M | -32.9M |
| Quarter End | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 70.67M | 62.97M | 58.86M | 54.29M | 49.24M |
| Total Liabilities | 3.52M | 2.81M | 2.45M | 2.77M | 2.31M |
| Total Equity | 67.15M | 60.16M | 56.41M | 51.52M | 46.94M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 44.35M | 816.88M | 353.74M | 275.18M | 246.1M |
| Total Liabilities | 2.95M | 61.25M | 5.11M | 5.79M | 5.7M |
| Total Equity | 41.4M | 755.63M | 348.64M | 269.39M | 240.4M |
| Quarter End | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.84M | -33.65M | -3.53M | -7.43M | -11.42M |
| Investing | -1.15M | -1.41M | -34k | -82k | -114k |
| Financing | 33.32M | 32.5M | 201k | 201k | 201k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.54M | -18.27M | -65.15M | 69.45M | -14.82M |
| Investing | -122k | 674.8M | -3.73M | -3.53M | -63.89M |
| Financing | 513k | 42.1M | -409.72M | -67.01M | N/A |
| Market Cap | 114.14M |
| Price to Earnings Ratio | -3.47 |
| Price to Sales Ratio | 28.47 |
| Price to Cash Ratio | 0.73 |
| Price to Book Ratio | 0.47 |
| Dividend Yield | - |
| Shares Outstanding | 30.44M |
| Average Volume (1 week) | 15.02k |
| Average Volume (1 Month) | 19.18k |
| 52 Week Change | 17.92% |
| 52 Week High | 6.69 |
| 52 Week Low | 3.00 |
| Spread (Intraday) | 3.8 (71.7%) |
| Company Name | XBiotech Inc |
| Address |
5217 winnebago ln, austin, tx 78744 austin, texas 78744 |
| Website | https://www.xbiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
